Telomerase activity in proximal and distal gastric neoplastic and preneoplastic lesions using immunohistochemical detection of hTERT

Digestive and Liver Disease

Volumn 37, Issue 6, 2005, Pages 439-445

  Gulmann, C ^a   Lantuejoul, S ^b   Grace, A ^a   Leader, M ^a   Patchett, S ^a   Kay, E ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b HÔPITAL MICHALLON   (France)

Author keywords

Cardia; Gastric carcinoma; hTERT; Immunohistochemistry; Telomerase

Indexed keywords

RETINOBLASTOMA PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; DNA BINDING PROTEIN; TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA; CARCINOMA; INTESTINE; INTESTINE MUCOSA; METABOLISM; METAPLASIA; MIDDLE AGED; PATHOLOGY; PRECANCER; STOMACH TUMOR;

AGED; CARCINOMA; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; RETINOBLASTOMA PROTEIN; STOMACH NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 26944484850     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.01.008     Document Type: Article

References (45)

1. Adanja B., Gledovic Z., Pekmezovic T., Vlajinac H., Jarebinski M., Zivaljevic V., et al. Mortality trends of malignant tumours of digestive organs in Belgrade, Yugoslavia. Dig Liver Dis 32 (2000) 386-391
2. Blot W.J., Devesa S.S., Kneller R.W., and Fraumeni Jr. J.F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc 265 (1991) 1287-1289
3. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
4. Ruol A., Parenti A., Zaninotto G., Merigliano S., Costantini M., Cagol M., et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 88 (2000) 2520-2528
5. van Dekken H., Alers J.C., Riegman P.H., Rosenberg C., Tilanus H.W., and Vissers K. Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am J Pathol 158 (2001) 1961-1967
6. Morales T.G., Camargo E., Bhattacharyya A., and Sampliner R.E. Long-term follow-up of intestinal metaplasia of the gastric cardia. Am J Gastroenterol 95 (2000) 1677-1680
7. Sipponen P. Intestinal metaplasia and gastric carcinoma. Ann Clin Res 13 (1981) 139-143
8. Hirota W.K., Loughney T.M., Lazas D.J., Maydonovitch C.L., Rholl V., and Wong R.K. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116 (1999) 277-285
9. Pieramico O., and Zanetti M.V. Relationship between intestinal metaplasia of the gastro-oesophageal junction. Helicobacter pylori infection and gastro-oesophageal reflux disease: a prospective study. Dig Liver Dis 32 (2000) 567-572
10. Fireman Z., Wagner G., Weissman J., Kopelman Y., Wagner Y., Groissman G., et al. Prevalence of short-segment Barrett's epithelium. Dig Liver Dis 33 (2001) 322-325
11. Spechler S.J., Zeroogian J.M., Antonioli D.A., Wang H.H., and Goyal R.K. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 344 (1994) 1533-1536
12. Ormsby A.H., Kilgore S.P., Goldblum J.R., Richter J.E., Rice T.W., and Gramlich T.L. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventive strategies in Barrett's esophagus. Mod Pathol 13 (2000) 614-620
13. de Lange T. Human telomeres are attached to the nuclear matrix. EMBO J 11 (1992) 717-724
14. Tahara E., Semba S., and Tahara H. Molecular biological observations in gastric cancer. Semin Oncol 23 (1996) 307-315
15. Newbold R.F. The significance of telomerase activation and cellular immortalization in human cancer. Mutagenesis 17 (2002) 539-550
16. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90 (1997) 785-795
17. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18 (1998) 65-68
18. Ito H., Kyo S., Kanaya T., Takakura M., Inoue M., and Namiki M. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res 4 (1998) 1603-1608
19. Takakura M., Kyo S., Kanaya T., Tanaka M., and Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 58 (1998) 1558-1561
20. Tahara H., Kuniyasu H., Yokozaki H., Yasui W., Shay J.W., Ide T., et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1 (1995) 1245-1251
21. Yasui W., Tahara H., Tahara E., Fujimoto J., Nakayama J., Ishikawa F., et al. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas. Jpn J Cancer Res 89 (1998) 1099-1103
22. Yasui W., Tahara E., Tahara H., Fujimoto J., Naka K., Nakayama J., et al. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach. Jpn J Cancer Res 90 (1999) 589-595
23. Kuniyasu H., Domen T., Hamamoto T., Yokozaki H., Yasui W., Tahara H., et al. Expression of human telomerase RNA is an early event of stomach carcinogenesis. Jpn J Cancer Res 88 (1997) 103-107
24. Hiyama T., Yokozaki H., Kitadai Y., Tahara E., Tahara H., Ide T., et al. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions. Jpn J Cancer Res 89 (1998) 1187-1194
25. Suzuki K., Kashimura H., Ohkawa J., Itabashi M., Watanabe T., Sawahata T., et al. Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions. J Gastroenterol Hepatol 15 (2000) 744-751
26. Jong H.S., Park Y.I., Kim S., Sohn J.H., Kang S.H., Song S.H., et al. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 86 (1999) 559-565
27. Maruyama Y., Hanai H., Fujita M., and Kaneko E. Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn J Clin Oncol 27 (1997) 216-220
28. Yang S.M., Fang D.C., Luo Y.H., Lu R., Battle P.D., and Liu W.W. Alterations of telomerase activity and terminal restriction fragment in gastric cancer and its premalignant lesions. J Gastroenterol Hepatol 16 (2001) 876-882
29. Usselmann B., Newbold M., Morris A.G., and Nwokolo C.U. Telomerase activity and patient survival after surgery for gastric and oesophageal cancer. Eur J Gastroenterol Hepatol 13 (2001) 903-908
30. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
31. Kyo S., Masutomi K., Maida Y., Kanaya T., Yatabe N., Nakamura M., et al. Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase. Am J Pathol 163 (2003) 859-867
32. Tahara H., Yasui W., Tahara E., Fujimoto J., Ito K., Tamai K., et al. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 18 (1999) 1561-1567
33. Shroyer K.R. Immunohistochemical markers of cell immortality. Hum Pathol 33 (2002) 683-685
34. Lantuejoul S., Soria J.C., Moro- Sibilot D., Morat L., Veyrenc S., Lorimier P., et al. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 90 (2004) 1222-1229
35. Lauren P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. APMIS 64 (1965) 31-49
36. Gulmann C., Grace A., Leader M., Butler D., Patchett S., and Kay E. Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays. Appl Immunohistochem Mol Morphol 11 (2003) 230-237
37. Gulmann C., Hegarty H., Grace A., Leader M., Patchett S., and Kay E. Differences in proximal (cardia) versus distal (antral) gastric carcinogenesis via the retinoblastoma pathway. World J Gastroenterol 10 (2004) 17-21
38. Morales C.P., Lee E.L., and Shay J.W. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer 83 (1998) 652-659
39. Hiyama E., Yokoyama T., Tatsumoto N., Hiyama K., Imamura Y., Murakami Y., et al. Telomerase activity in gastric cancer. Cancer Res 55 (1995) 3258-3262
40. Djojosubroto M.W., Choi Y.S., Lee H.W., and Rudolph K.L. Telomeres and telomerase in aging, regeneration and cancer. Mol Cells 15 (2003) 164-175
41. Etheridge K.T., Banik S.S., Armbruster B.N., Zhu Y., Terns R.M., Terns M.P., et al. The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem 277 (2002) 24764-24770
42. Wong J.M., Kusdra L., and Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 4 (2002) 731-736
43. Sobin LH, Wittekind Ch, editors. TNM classification of malignant tumours. 6th ed. John Wiley & Sons Inc.; 2002.
44. Feakins R.M., Nickols C.D., Bidd H., and Walton S.J. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival. Hum Pathol 34 (2003) 1276-1282
45. Lan J., Xiong Y.Y., Lin Y.X., Wang B.C., Gong L.L., Xu H.S., et al. Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation. World J Gastroenterol 9 (2003) 54-58